NCT07029204Early phase 1Active, not recruiting
Intralesional Cyclosporine for Alopecia Areata
Pilot Study on Intralesional Cyclosporine for Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Early phase 1
- Sponsor
- University of California, Davis
- Participants (registry)
- 2
- Start
- August 2025
- Primary completion
- October 2026
- Study completion
- October 2026
- Last registry update
- August 2026
- Countries
- United States
Conditions studied: Alopecia Areata
Interventions: CycloSPORINE Injectable Product, Saline Solution
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.